Preliminary fourth quarter 2024 revenue of approximately $2.41 billion increased by 25% compared with $1.93 billion in the fourth quarter of 2023. Preliminary 2024 revenue of approximately $8.35 ...
As set forth above, the company’s financial results for the quarter and full year ended December 31, 2024 set forth in this press release are preliminary and subject to Myriad Genetics’ normal quarter ...
A common thread among these themes is the need for courage — courage to implement commonsense and well-known solutions to pressing and longstanding problems; courage to challenge the deeply entrenched ...